Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens
February 23, 2011 08:55 ET
|
Immunovaccine Inc.;Immunotope Inc.
DOYLESTOWN, PENNSYLVANIA and HALIFAX, NOVA SCOTIA--(Marketwire - Feb. 23, 2011) - Immunotope Inc. and Immunovaccine Inc. (TSX VENTURE:IMV) announced today that the U.S. Patent and...
Immunovaccine Provides Corporate Update
February 10, 2011 08:31 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwire - Feb. 10, 2011) - Immunovaccine Inc. (TSX VENTURE:IMV), a clinical-stage vaccine development Company, is pleased to provide an update on corporate...
Immunovaccine Announces Issuance of Common Shares to a Consultant
February 02, 2011 17:30 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwire - Feb. 2, 2011) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV) announced today that it has issued 12,000 common...
Immunovaccine to Present at Biotech Showcase(TM) 2011
January 05, 2011 08:56 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwire - Jan. 5, 2011) - Immunovaccine Inc. (TSX VENTURE:IMV) announced today that Dr. Randal Chase, President and CEO, will present at Biotech Showcase on...
Immunovaccine Announces Issuance of Common Shares to a Consultant
January 04, 2011 17:30 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwire - Jan. 4, 2011) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV) announced today that it has issued 11,843 common shares of its...